Every intervention Outliyr has scored for more energy, ranked by its BioHarmony score for this use case rather than its overall rating. The number beside each name is how well that one thing works for more energy; the tier beside it is what it is worth once safety, cost and effort are counted across everything else.
84 of 144 evaluated interventions score 3.0+ out of 10 for more energy · 21 comparisons
Borra 2025 anchors the strongest signal. The existing rationale points to this narrower claim: Dehydration-related fatigue can correct quickly with water and electrolytes. The effect is strongest when symptoms appear after sweat,…
Watanabe 2002 reports Cognitive performance under mental load and sleep deprivation. The score stays conditional because Creatine Monohydrate still needs better outcome data for this exact use case. The practical move is…
De Baaij 2015 anchors the most relevant signal. Magnesium fits energy when low intake, stress load, mineral loss, or a form-specific target makes deficiency correction plausible. The score stays bounded because effects…
Red Light Therapy acts on mitochondrial photobiology, with Karu 2010 supporting ATP-related mechanisms at cytochrome c oxidase. The human outcome is more variable than the mechanism. Low-baseline users, overtrained athletes, and people…
The evidence points to a plausible use case without proving a universal response. Mann G et al. 2026 is the best anchor here because it reports five studies meta-analyzed, 997 participants and…
Lincoff 2023 reports TRAVERSE cardiovascular outcomes trial in 5,246 hypogonadal men with cardiovascular risk; major cardiovascular events non-inferior, with monitoring-relevant safety signals. Cruickshank 2024 points in the same direction, but route, dose,…
Reliable acute stimulation via direct + indirect adrenergic activation; Tmax 1.8 hours, peak effect 1-2 hours. Tachyphylaxis develops within 2-4 weeks of continuous use. Caffeine + L-tyrosine + adequate sleep produce comparable…
Rodriguez 2016 makes the claim plausible but incomplete. The existing rationale points to this narrower claim: Subjective energy is a consistent user report and fits the redox mechanism, but human evidence is…
Kodama 2009 supports direction more than certainty. The existing rationale points to this narrower claim: Daytime energy is a common downstream benefit as mitochondrial capacity, glucose handling, and sleep improve. Zone 2…
Dhillon 2024 reports 25-article systematic review; mixed preliminary clinical evidence, heterogeneity, and need for stronger trials. Zhou 2024 points in the same direction, but route, dose, baseline status, and outcome tracking decide…
Pandit 2016 anchors the most relevant signal. Shilajit fits energy when purified resin is matched to hormones, sperm parameters, strength fatigue, bone markers, or energy tracking. The score stays bounded because most…
Fatigue and asthenia are the best-supported clinical use case for Bromantane. The Voznesenskaia 2010 multicenter trial in 728 outpatients with asthenic syndrome reported a CGI-I responder rate of 90.8% at 50 to…
The most plausible benefit is acute perceived energy or stimulant-like activation. The strongest support comes from Yoo C. et al. 2021, but the practical rating stays bounded by study size, replication, and…
A Cochrane review of nine trials (7,111 participants) reports that Tirzepatide produces roughly a 10% body-weight reduction versus placebo, which is the primary driver of any perceived boost in energy Franco 2025.…
Marzbani et al. 2016 supports the main pathway. Energy effects are secondary. Users may feel more mentally clear when attention, sleep, and arousal regulation improve, but neurofeedback is not a mitochondrial or…
The original trial reported a clear VO2max gain after six weeks Helgerud 2007. Better aerobic capacity can make daily tasks feel easier, but trials usually measure fitness rather than subjective energy. The…
CoQ10's role in ATP synthesis makes restored energy plausible where levels are low, such as statin users, older adults, or those with fatigue tied to cardiac or mitochondrial issues, and exercise capacity…
Tambi 2012 makes the claim plausible but incomplete. The existing rationale points to this narrower claim: Energy claims are mostly downstream of stress, mood, and testosterone-to-cortisol changes rather than direct fatigue trials.…
Higher aerobic capacity from SIT, shown as a rapid VO2max gain in Gist 2014 and a near-doubling of endurance capacity in Burgomaster 2005, makes daily tasks feel easier over a few weeks.…
The evidence points to a plausible use case without proving a universal response. Sun Y et al. 2025 is the best anchor here because it reports 20 randomized trials, 1,242 participants and…
Hagiyama 2024 reports 12 RCTs; 622 patients; low-certainty improvement in patient-reported outcomes and very-low-certainty strength signal after lower-limb surgeries. Wittholz 2024 points in the same direction, but route, dose, baseline status, and…
Soh 2024 anchors the most relevant signal. Glycine fits energy because glycine participates in sleep signaling, glutathione, collagen, methylation, and nervous-system balance, depending on the endpoint. The score stays bounded because many…
Energy benefits are mostly indirect through better sleep and lower sympathetic load; no strong direct energy endpoint supports a higher rating. The score stays bounded because Vagus Nerve Stimulation evidence for energy…
Peng et al. 2024 reported a 7 % increase in concentric knee extensor torque after a single Whole-Body Vibration session, suggesting an acute boost in muscular power. Users frequently describe a short-term…
Leung GKW et al. 2025 is the best anchor here because it reports 33 randomized trials and 2821 individuals and ketogenic/low-carbohydrate diets reduced body weight, BMI, and body-fat percentage, with stronger subgroup…
Reduced SASP inflammation may improve subjective energy in older or inflamed users, but human F+Q energy outcomes remain untested. The score stays bounded because Senolytics evidence for energy can depend on age,…
Wang 2024 anchors the most relevant signal. NMN fits energy when raising NAD+ is likely to matter for older, metabolically stressed, or performance-tracking users. The score stays bounded because NAD+ rises more…
The most plausible benefit is acute perceived energy or stimulant-like activation. The strongest support comes from Cintineo H. et al. 2022, but the practical rating stays bounded by study size, replication, and…
The evidence for SLU-PP-332's impact on energy is limited to a single mouse study that reported a 12% increase in treadmill endurance and was documented by Billon et al. 2023. The proposed…
Shahmirzadi 2020 supports direction more than certainty. The existing rationale points to this narrower claim: Mechanistic energy-metabolism rationale exists, and Nick notes subjective performance benefit, but there are no controlled human energy…
The most plausible benefit is acute perceived energy or stimulant-like activation. The strongest support comes from Malykh A. et al. 2010, but the practical rating stays bounded by study size, replication, and…
Reduced fatigue as secondary outcome across multiple anxiety/depression studies. The score stays bounded because HRV Biofeedback evidence for energy can depend on breathing cadence, adherence, baseline HRV, and symptom tracking. In practice,…
Fatigue is one of the earliest and most reversible symptoms of vitamin C deficiency. Genuinely low people, including smokers and those with poor diets, often report meaningful energy improvement on repletion, and…
Kalafati 2010 used a double-blind crossover in 9 trained men at 6 g/day for 4 weeks and found time to fatigue rising from 2.05 to 2.70 minutes with a 10.9 percent rise…
Harrison 2009 anchors the most relevant signal. Rapamycin fits energy when mTORC1 modulation, autophagy, immune aging, or senescence biology is the actual target. The score stays bounded because human longevity endpoints remain…
Improved mitochondrial fuel oxidation and lower oxidative stress are energy-relevant, and older participants reported better physical function, but there is no dedicated fatigue endpoint with a clean placebo comparison. Treat any energy…
MOTS-c earns an energy score from exercise-mimetic AMPK activation, Reynolds 2021 exercise biology, and Nick's subjective energy response. Human energy endpoints remain unvalidated. That makes MOTS-c more defensible when energy is a…
The most plausible benefit is acute perceived energy or stimulant-like activation. The strongest support comes from Copani A. et al. 1992, but the practical rating stays bounded by study size, replication, and…
Semaglutide can improve fatigue tied to obesity and glucose swings, but it can also cause fatigue through low intake, dehydration, nausea, or rapid weight loss. Wilding 2021 supports weight reduction, which is…
Mixed and individual. Some users report a clean acute energy and focus lift from the rapid fuel shift, since the brain and muscle readily use BHB as a substrate; others feel GI-driven…
Daytime energy and reduced tiredness are among the more believable felt effects of this class. The human support is the Tang 2005 reishi trial, where neurasthenia patients reported a 28.3 percent drop…
Some users report energy improvements after full protocols, especially with fatigue syndromes, but Kjellberg 2025 weakens short-course long-COVID fatigue expectations.
Improved functional capacity can raise perceived energy over time, but BFR is not an acute energy intervention.
Many users report a refreshed, energized feeling after a session and the cooling rebound, but sauna is not a stimulant and there is no objective energy or fatigue trial for traditional sauna.…
Some users report energy lift and exercise-efficiency reviews are directionally positive, but astaxanthin is not an acute stimulant.
Better muscle function can translate to better daily energy, especially in deconditioned users. Evidence is indirect from strength and function outcomes rather than EMS-specific fatigue trials, so the score remains moderate.
Regular aerobic conditioning typically improves daytime stamina and reduces fatigue over weeks, but rucking is also a genuine energy cost in the session and can drain you if load and volume are…
T2D users may feel more energy when glucose normalizes, while healthy users can experience fatigue or training-output tradeoffs. The direct energy score stays below neutral.
Some users report steadier energy on chlorella, plausibly from correcting iron, B-vitamin, or general micronutrient gaps, but there is no controlled human evidence that it raises energy as a primary effect. It…
People with high oxidative-stress burden sometimes report better energy when glutathione status improves, and fatigue is the most common positive anecdote, but there is no dedicated fatigue RCT for glutathione supplementation with…
NAD+ is essential for cellular energy metabolism, but most healthy adults report no obvious subjective energy effect despite biochemical elevation.
Restoring ETC efficiency should improve cellular energy production, but Nick's N=1 was neutral and Karaa 2023 did not confirm broad PMM fatigue benefit.
Acute mental energy is one of the more common community-reported benefits, but no formal fatigue, vitality, or mental-energy endpoint trial verifies the effect.
Not a stimulant. Any fatigue benefit would be slow and antioxidant-mediated; no dedicated energy or fatigue trial supports a meaningful effect.
Mitochondrial biomarker changes can translate into energy for some low-baseline users, but subjective energy reports are mixed and not a proven acute effect.
Improved VAT, sleep quality, and metabolic markers may improve subjective energy in selected users. Tesamorelin has no stimulant mechanism, and energy outcomes were not primary endpoints in the pivotal evidence.
Some users report a hydration or energy lift, but there is no controlled trial of Quinton for fatigue, and the mineral dose per ampoule is modest.
Pine pollen supplies amino acids, B vitamins, and minerals, which gives a nutritional basis for a general vitality effect, and TCM has used song hua fen as an energy tonic for centuries.…
Community reports improved energy and vitality; GH elevation can feel energizing, but this is not verified by controlled CJC-1295 outcome trials.
Energy gains are an indirect downstream of better tissue repair, recovery, and inflammation control, not a direct Tβ4 mechanism. No trial has measured energy or fatigue endpoints.
Some users report a subtle lift tied to better oxidative balance, but NAC is not a stimulant and has no direct energy or fatigue RCT base in healthy people.
Indirect via mitochondrial quality control; no subjective-energy RCT.
Indirect via reduced inflammation and improved tissue function. Energy claims are secondary and should be interpreted as feeling better after an injury heals, not direct mitochondrial stimulation.
Energy effects are indirect through mood, sleep, gut-brain, and inflammation pathways. Lion's Mane is not a primary energy compound and should not be positioned like caffeine or creatine.
Energy effects are restorative rather than stimulating. Users with poor sleep, elevated stress, or burnout-like physiology may feel more stable energy after stress improves. Low-stress users may feel sedated or blunted instead,…
Fatigue improved in some cancer-support studies and not others; not an acute energy agent.
Acute energy lift from sustained catecholamine elevation is one of the most reliable subjective effects in the cold-plunge corpus. Sramek 2000 documented the magnitude (NE +530 percent, DA +250 percent at 14…
Energy is the most-reported subjective effect, and Nick feels it within 30 minutes, but no trial has measured it. The plausible route is restored NAD+ supporting cellular energy production.
Indirect via caffeine optimization. L-theanine is not a primary energy intervention and may feel flattening in already-calm users.
Any acute lift from coffee or tea is caffeine, not the polyphenols.
Energy remains a 3 because mitochondrial and repair-gene claims are indirect. No human fatigue, ATP, or performance endpoint trial supports GHK-Cu for energy. Pickart 2018 is the review-level background.
Some users report better energy during illness, but no objective fatigue or energy endpoint is established. Effects likely reflect recovery from immune suppression rather than stimulant-like energy.
Energy has no direct saffron RCT endpoint; any lift is indirect through better mood, lower perceived stress, and better sleep quality.
Russian clinical reports describe antiasthenic effects, and anxiety reduction often improves perceived energy. There is no fatigue-specific RCT.
Energy may improve when glucose volatility improves, but berberine is not an energizing supplement for healthy users. Complex I inhibition makes fatigue a plausible issue in some.
Energy benefits are indirect through fewer illness days or less gut stress during training. Bovine colostrum is not an acute energy substrate, stimulant, or mitochondrial enhancer.
Quality-of-life improvements in Russian elderly peptide literature included energy and vitality-like outcomes, but objective energy-metabolism endpoints are absent. Any energy effect is likely secondary to sleep or circadian rhythm rather than direct…
Some people report steadier energy as gut inflammation settles, but no direct fatigue trials support this. Indirect at best.
Some people report steadier energy from lower inflammation, but no direct fatigue trials support this as a primary use.
Glucagon is thermogenic and weight loss can improve daily energy in metabolic disease, but nausea and sustained caloric deficit can reduce energy. Retatrutide has no direct fatigue or vitality endpoint.
Energy is the headline marketed claim and the most common same-session report after IV NAD+, but it rests on subjective drip-feel rather than controlled measurement. The one human study is pharmacokinetic, not…
Energy and alertness are a side consequence of the stimulant-class mechanism, not a clean benefit. Raising central noradrenaline and dopamine produces a wakeful, appetite-suppressed state, and the modest rise in energy expenditure,…
Neither direct human RCT established a reliable subjective energy or objective fatigue benefit at 200 mg/day. Robinson 2024 (Robinson 2024) was designed around overweight and obesity biomarkers, while Chooi 2024 TANGO focused…
Anecdotal energy reports are common but uncontrolled. Longecity users describe stamina shifts, yet placebo contribution and responder bias are large. The proposed mitochondrial mechanism has no human ATP, respiration, or biogenesis endpoint…
Nothing matches those filters.
Monthly out-of-pocket cost at the most accessible legitimate channel, at the dose the score was given for. 28 of 84 are not priced yet; those cells are left blank rather than guessed.
| Intervention | Monthly cost | At dose | How you get it |
|---|---|---|---|
| Electrolytes | Not priced yet | ||
| Creatine Monohydrate | Not priced yet | ||
| Magnesium | $10–$20 | 200-400 mg glycinate elemental | Over the counter |
| Red Light Therapy | $17–$43 | 10-20 min at 6-12 inches, full chest/face/back rotation | Over the counter |
| Modafinil | $18–$35 | 200 mg oral tablet | Prescription |
| TRT (Testosterone Replacement Therapy) | $50–$300 | Clinician-selected formulation at the lowest dose likely to restore physiologic testosterone | Prescription |
| Ephedrine | Not priced yet | ||
| Methylene Blue | $13–$40 | 0.5-5 mg oral | Over the counter |
| Zone 2 Cardio | Not priced yet | Over the counter | |
| Molecular Hydrogen | Not priced yet | ||
| Shilajit | $25–$50 | 500 mg purified shilajit | Over the counter |
| Bromantane (Ladasten) | $12–$30 | 30 mg | Grey market |
| Paraxanthine (Enfinity) | Not priced yet | ||
| Tirzepatide | $299–$449 | 2.5 to 5 to 7.5 to 10 to 12.5 to 15 mg | Prescription |
| Neurofeedback | Not priced yet | ||
| Norwegian 4×4 | Not priced yet | Over the counter | |
| Coenzyme Q10 (CoQ10 / Ubiquinol) | $15–$40 | 100-200 mg/day | Over the counter |
| Tongkat Ali | $20–$40 | 200 mg/day Physta standardized extract | Over the counter |
| Sprinting (Sprint Interval Training) | Not priced yet | ||
| Time-Restricted Eating | Not priced yet | ||
| Essential Amino Acids | Not priced yet | ||
| Glycine | $2–$3 | 3 g oral glycine | Over the counter |
| Vagus Nerve Stimulation | $4–$8 | 10-20 min auricular tVNS at comfortable perceptible intensity | Over the counter |
| Whole-Body Vibration | $50–$100 | 30 Hz, roughly 0.3g, 10-20 min standing | Over the counter |
| Ketogenic Diet | $100 | Standard keto, 40-50 g total carbohydrate/day | Over the counter |
| Senolytics | Not priced yet | ||
| NMN (Nicotinamide Mononucleotide) | $40–$100 | 500 mg/day oral | Over the counter |
| Dynamine (Methylliberine) | Not priced yet | ||
| SLU-PP-332 | $30–$80 | 3-5 mg/day oral | Research use only |
| Ca-AKG (Calcium Alpha-Ketoglutarate) | $15–$30 | 1 g/day generic Ca-AKG oral | Over the counter |
| Phenylpiracetam (Phenotropil) | $21–$42 | 100-200 mg | Grey market |
| HRV Biofeedback | $5 | 20 min/session at individual RF (4.5 to 6.5 bpm) | Over the counter |
| Vitamin C (Ascorbic Acid) | Not priced yet | ||
| Spirulina | $10–$25 | 1 to 4.5 g/day | Over the counter |
| Rapamycin | $15–$50 | 3 mg | Prescription |
| GlyNAC (Glycine + N-Acetylcysteine) | $10–$30 | Glycine and NAC at ~100 mg/kg/day each | Over the counter |
| MOTS-c | $100–$200 | 5-10 mg SC | Research use only |
| Oxiracetam | $15–$40 | 800-2,400 mg | Grey market |
| Semaglutide | $199–$349 | 0.25 mg weeks 1 to 4, 0.5 mg weeks 5 to 8, 1.0 mg weeks 9 to 12, 1.7 mg weeks 13 to 16, 2.4 mg week 17 onward | Prescription |
| Exogenous Ketones | $38–$300 | Ester 10 to 25 g BHB | Over the counter |
| Adaptogenic Mushrooms (Reishi, Cordyceps, Chaga) | $15–$40 | 1.5 to 1.8 g/day standardized extract | Over the counter |
| Hyperbaric Oxygen Therapy | $3,000–$6,000 | 2.0 ATA for 90 minutes with air breaks | In clinic |
| Blood-Flow Restriction Training | Not priced yet | ||
| Traditional Sauna (Finnish Dry-Heat) | $50 | 15 to 20 minutes at 80 to 100 C | Over the counter |
| Astaxanthin | Not priced yet | ||
| Full-Body EMS | Not priced yet | ||
| Rucking (Weighted Walking) | Not priced yet | ||
| Metformin | $4–$30 | 500 mg with dinner for 1 week, then 500 mg twice daily for 1 week, then increase by 500 mg/week toward 1000 mg twice daily as tolerated | Prescription |
| Chlorella | $10–$50 | 5-10 g/day | Over the counter |
| Glutathione (GSH) | $20–$45 | 1,000 mg/day | Over the counter |
| NR (Nicotinamide Riboside) | $40–$50 | 250-300 mg/day oral | Over the counter |
| SS-31 (Elamipretide) | $200–$500 | 5-10 mg/day subcutaneous | Grey market |
| Semax | $12–$60 | 300-600 mcg/day of 0.1% spray | Grey market |
| Ergothioneine | Not priced yet | ||
| Urolithin A | $50–$100 | 500 mg/day | Over the counter |
| Tesamorelin | $250–$500 | 2 mg subcutaneous daily in the evening | Prescription |
| Quinton Marine Plasma (Seawater Minerals) | Not priced yet | ||
| Pine Pollen | $20–$45 | 5 to 10 g powder per day | Over the counter |
| CJC-1295 | $80–$200 | 1-2 mg subcutaneous | Grey market |
| Thymosin Beta-4 (Tβ4) | Not priced yet | ||
| NAC (N-Acetylcysteine) | $5–$15 | 600 to 1,200 mg/day | Over the counter |
| Spermidine | $40–$90 | 1-3 mg/day oral WGE | Over the counter |
| BPC-157 | $40–$80 | 250 to 500 mcg SC 1 to 2x/day near injury site | Grey market |
| Lion’s Mane | $20–$40 | 3 g/day fruiting body extract | Over the counter |
| Ashwagandha | $15–$30 | 300 mg KSM-66 with breakfast and 300 mg with dinner | Over the counter |
| Fucoidan (Brown Seaweed Polysaccharide) | Not priced yet | ||
| Cold Plunge | Not priced yet | Over the counter | |
| 5-Amino-1MQ | $95–$190 | 50 to 100 mg oral, once daily | Grey market |
| L-Theanine | $3–$8 | 200 mg L-theanine + 100 mg caffeine | Over the counter |
| Polyphenols (Dietary) | Not priced yet | ||
| GHK-Cu | $30–$100 | 0.5-3% topical serum or cream | Over the counter |
| Thymosin Alpha-1 | $100–$400 | 1.6 mg subcutaneous | Prescription |
| Saffron | Not priced yet | ||
| Selank | $30–$60 | 0.15% intranasal spray, roughly 1-3 sprays per nostril per day depending on actuation size | Grey market |
| Berberine | $15–$25 | 500 mg berberine HCl three times daily with meals | Over the counter |
| Colostrum | $60–$80 | 20 g/day powder, split AM/PM if tolerated | Over the counter |
| Epitalon | $95–$1,100 | 5-10 mg/day subcutaneous | Grey market |
| Sodium Butyrate | Not priced yet | ||
| Curcumin | $15–$40 | 500 mg curcuminoids | Over the counter |
| Retatrutide | $130–$960 | 2 mg, then 4 mg, then 8 mg or 12 mg weekly depending on protocol and tolerability | Research use only |
| NAD+ (Direct) | $300–$1,600 | 250 to 750 mg | In clinic |
| Tesofensine | Not priced yet | ||
| C15 (Pentadecanoic Acid) | $40–$50 | 200 mg/day | Over the counter |
| C60 (Buckminsterfullerene) | Not priced yet |
Head-to-head reports and category rankings that name a winner on this use case.
This page ranks by the live body-composition subrating, not the overall BioHarmony score, since body composition is the goal this category is built around. Tirzepatide leads both measures.…
This page ranks by the live endurance-cardio subrating, not by BioHarmony overall, and the order flips. SLU-PP-332 leads at 6.5–7.0/10 despite carrying the lowest overall score on the…
This page ranks by the live Body Composition subrating, fat loss and body composition, not the overall BioHarmony score. Tesamorelin leads at 7.5–8.0/10, and it also carries the…
Ranked by the live Focus and cognition subrating, not the overall score. Methylene blue leads at 6.5–7.0/10 despite a lower overall, 6.0–6.5/10. Bromantane climbs from ninth to fourth.…
This page ranks by hormonal fit, not overall BioHarmony score. TRT leads at 9.0–9.5/10. Phosphatidylserine sits fifth at 5.5–6.0/10 despite the second highest overall score here, 7.0–7.5/10. That…
Neither, if fat loss is the goal. Both score 2.0–2.5/10 on body composition, which is the row a vendor sells them on. AOD-9604 scores 3.0–3.5/10 overall and its…
Bromantane, for anything you plan to repeat. It scores 7.0–7.5/10 against phenylpiracetam's 5.5–6.0/10 and wins every shared use case that is not a floor tie: energy 6.2/10 to…
CoQ10 scores 7.0–7.5/10 and methylene blue 6.0–6.5/10, yet methylene blue wins eleven of the seventeen shared use cases. The overall gap is risk, not effect. Methylene blue inhibits…
The scores tie at 6.0–6.5/10 and 6.0–6.5/10 and every shared subrating sits within half a point, so the numbers decide nothing. Access and evidence decide it. Gonadorelin is…
Kisspeptin-10 scores 6.0–6.5/10 and TRT 5.5–6.0/10, and TRT still wins 13 of the 15 use cases both reports score. The higher number reflects dependency and reversibility, not effect.…
They solve different problems and the scores hide that. Oxytocin scores 6.5–7.0/10 against PT-141's 5.0–5.5/10, mostly on safety and cost. PT-141 still wins libido 5.5/10 against 2.5/10. Oxytocin…
Shilajit scores 7.0–7.5/10 and ashwagandha 6.5–7.0/10, but that gap is the least useful number here. These two do different jobs. Shilajit is the mineral and androgen play: male…
Electrolytes, at 7.5–8.0 out of 10 for more energy. Borra 2025 anchors the strongest signal.
Of the top-scoring options, Glycine is the least expensive at about $2 a month, scoring 5.5–6.0 out of 10 for more energy.
C15 (Pentadecanoic Acid) scores 3.0–3.5 out of 10 for more energy but only 3.0–3.5 overall, landing in the caution tier once safety, side effects, cost and effort are counted.
84 of the 144 interventions evaluated for more energy score 3.0 out of 10 or better, which is the cut-off for appearing on this page.
